MDMatthew T. Davis

Matthew T. Davis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Matthew T. Davis has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prediction of transformative breakthroughs in biomedical research

    by Matthew T. Davis, Brad L. Busse, Salsabil Arabi, Payam Meyer, Travis A. Hoppe, Rebecca A. Meseroll, B. Ian Hutchins, Kristine A. Willis, George M. Santangelo

    The ability to predict scientific breakthroughs at scale would accelerate the pace of discovery and improve the efficiency of research investments. Recent advances in artificial intelligence, graph theory, and computing power have provided new ways to pursue this elusive goal. We have identified a common signature within co-citation networks that accurately predicts the occurrence of breakthroughs in medical research, on average more than 5 years in advance of the subsequent publication(s) that announced the discovery. A combination of features produces these diagnostic signals: a burst of papers exploring a novel scientific concept, an unusually high number of very influential papers in specialty journals, and low topical cohesion of the associated content. We analyzed two different periods separated by 20 years to show that the kinetics of breakthrough formation are conserved, suggesting that our approach can be used to predict which topics will produce future transformative discoveries. Significance statement: Scientific breakthroughs are rare, as is contemporaneous recognition of their initial expression. Faster, more efficient identification of topics likely to produce future breakthroughs would speed scientific and technological progress. We introduce an AI/ML-detected signature in co-citation networks that recognizes such topics up to twelve years before the breakthrough itself occurs. Our findings illustrate how a better understanding of the scientific process may lead to greater scientific returns.


  • Open Access

    The effect of mentee and mentor gender on scientific productivity of applicants for NIH training fellowships

    by Hao Yu, Kristine A. Willis, Aviva Litovitz, Robert M. Harriman, Matthew T. Davis, Payam Meyer, Brad Busse, Rebecca A. Meseroll, Hashanthi D. Wijayatilake, Matthew J. Perkins, et al.

    Several studies have suggested that women in science are less productive than men, and that this gap contributes to their under-representation in the ranks of senior researchers. However, few studies have examined the role of mentoring, and in particular mentor gender, on the productivity of female scientists early in their careers. Such efforts are limited by the difficulties of unambiguously linking mentees to their mentors and measuring the research productivity resulting from those relationships. Here we use our novel author disambiguation solution to investigate the role of self-identified gender in mentorship of 12,932 trainees who either successfully or unsuccessfully applied to the National Institutes of Health for research fellowships between fiscal years 2011 and 2017, applying a multi-dimensional framework to assess productivity. We found that, after normalizing for the funding level of mentors, the productivity of female and male mentees is indistinguishable; it is also independent of the gender of the mentor, other than in measures of clinical impact, where women mentored by women outperform other mentee-mentor dyads.


  • Open Access

    The NIH Open Citation Collection: A public access, broad coverage resource

    by B. Ian Hutchins, Kirk L. Baker, Matthew T. Davis, Mario A. Diwersy, Ehsanul Haque, Robert M. Harriman, Travis A. Hoppe, Stephen A. Leicht, Payam Meyer, George M. Santangelo

    Citation data have remained hidden behind proprietary, restrictive licensing agreements, which raises barriers to entry for analysts wishing to use the data, increases the expense of performing large-scale analyses, and reduces the robustness and reproducibility of the conclusions. For the past several years, the National Institutes of Health (NIH) Office of Portfolio Analysis (OPA) has been aggregating and enhancing citation data that can be shared publicly. Here, we describe the NIH Open Citation Collection (NIH-OCC), a public access database for biomedical research that is made freely available to the community. This dataset, which has been carefully generated from unrestricted data sources such as MedLine, PubMed Central (PMC), and CrossRef, now underlies the citation statistics delivered in the NIH iCite analytic platform. We have also included data from a machine learning pipeline that identifies, extracts, resolves, and disambiguates references from full-text articles available on the internet. Open citation links are available to the public in a major update of iCite (https://icite.od.nih.gov).


  • Open Access

    Predicting translational progress in biomedical research

    by B. Ian Hutchins, Matthew T. Davis, Rebecca A. Meseroll, George M. Santangelo

    Fundamental scientific advances can take decades to translate into improvements in human health. Shortening this interval would increase the rate at which scientific discoveries lead to successful treatment of human disease. One way to accomplish this would be to identify which advances in knowledge are most likely to translate into clinical research. Toward that end, we built a machine learning system that detects whether a paper is likely to be cited by a future clinical trial or guideline. Despite the noisiness of citation dynamics, as little as 2 years of postpublication data yield accurate predictions about a paper’s eventual citation by a clinical article (accuracy = 84%, F1 score = 0.56; compared to 19% accuracy by chance). We found that distinct knowledge flow trajectories are linked to papers that either succeed or fail to influence clinical research. Translational progress in biomedicine can therefore be assessed and predicted in real time based on information conveyed by the scientific community’s early reaction to a paper.